Mendel Money Management Abb Vie Inc. Transaction History

Mendel Money Management

$208 Million
Q2 2024

A detailed history of Mendel Money Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Mendel Money Management holds 13,067 shares of ABBV stock, worth $2.55 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

13,067

Previous 13,283 1.63%

Holding current value

$2.55 Million

Previous $2.42 Million 7.32%

% of portfolio

1.08%

Previous 1.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $33,434 - $39,044	-216 Reduced 1.63%	13,067 $2.24 Million
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $63,288 - $72,111	-396 Reduced 2.89%	13,283 $2.42 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $1.88 Million - $2.12 Million	13,679 New	13,679 $2.12 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $62,787 - $72,685	470 Added 5.38%	9,212 $1.37 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $113,163 - $140,824	854 Added 10.83%	8,742 $1.18 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $1.03 Million - $1.19 Million	-7,141 Reduced 47.51%	7,888 $1.26 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $48,408 - $58,054	350 Added 2.38%	15,029 $2.43 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $91,933 - $105,442	685 Added 4.89%	14,679 $1.97 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $90,141 - $114,598	-655 Reduced 4.47%	13,994 $2.14 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $575,960 - $714,605	4,364 Added 42.43%	14,649 $2.38 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $44,046 - $55,731	-410 Reduced 3.83%	10,285 $1.39 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $4,788 - $5,435	-45 Reduced 0.42%	10,695 $1.15 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $57,865 - $64,465	-550 Reduced 4.87%	10,740 $1.21 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $10,230 - $11,262	-100 Reduced 0.88%	11,290 $1.22 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $25,756 - $34,774	320 Added 2.89%	11,390 $1.22 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $10,309 - $12,099	120 Added 1.1%	11,070 $970,000
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $39,473 - $52,820	538 Added 5.17%	10,950 $1.08 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $12,983 - $16,245	-180 Reduced 1.7%	10,412 $922,000
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $12,596 - $15,144	200 Added 1.92%	10,592 $802,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $24,637 - $31,492	375 Added 3.74%	10,392 $756,000
Q3 2018 Oct 29, 2018	SELL	$88.91 - $98.84 $65,259 - $72,548	-734 Reduced 6.83%	10,017 $947,000
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $962,859 - $1.06 Million	10,751	10,751 $1.04 Million

Others Institutions Holding ABBV

# of Institutions

3,697

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendel Money Management, based on Form 13F filings with the SEC.

News

Stay updated on Mendel Money Management with notifications on news.

Account

Mendel Money Management Abb Vie Inc. Transaction History